查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1750726

北美注射输液帮浦市场规模、份额、趋势分析报告：按适应症、最终用途、国家和细分市场预测，2025 年至 2030 年

North America Syringe Infusion Pumps Market Size, Share & Trends Analysis Report By Disease Indication (Pediatrics/neonatology, Chemotherapy, Diabetes, Gastroenterology), By End Use (Hospitals, Homecare), By Country, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10个工作天内

价格

北美注射输液帮浦市场的成长与趋势：

根据 Grand View Research, Inc. 的一份新报告，北美注射输液帮浦市场预计到 2030 年将达到 10.4 亿美元，2025 年至 2030 年的复合年增长率为 8.4%。

预计市场将经历显着成长，主要原因是慢性病盛行率不断上升（影响约六成美国成年人），以及对癌症和糖尿病等疾病进行精确和持续药物剂量治疗的需求。

外科手术和重症监护室（ICU）入院人数的增加，对帮浦的需求也随之增加，而帮浦对于麻醉剂和重症监护药物的给药至关重要。考虑到美国住院人数预计将从2025年的3,600万人增加到2035年的4,000万人，这种情况尤其明显。

智慧输液技术的进步，包括配药错误减少系统 (DERS) 以及与电子健康记录的兼容性，对于提高用药安全性和效率至关重要，北美在该领域的应用处于领先地位。受人口老化和成本控制策略的推动，家庭医疗保健和门诊护理行业不断扩张，推动了对便携式、易于使用的注射式帮浦的需求，以便在医院外安全地进行药物管理。良好的法规环境和报销政策进一步推动了市场的持续成长和技术创新。

北美注射器输液帮浦市场报告重点

  • 预计到 2024 年，小儿科/新生儿科将占据最大的收入份额，超过 25.0%。这是因为新生儿和婴儿迫切需要精确的药物输送，同时安全技术的进步和对 NICU/PICU 的投资。
  • 预计在预测期内，化疗部分将以最快的复合年增长率成长。
  • 市场成长的动力来自于对采用精确注射式帮浦输送强效药物的迫切需求以及安全措施的支持，以及癌症患者数量的不断增加。
  • 由于重症加护和多样化应用对精准药物传递的需求很高，预计医院将主导市场，占 2024 年总收入份额的约 40.0%。
  • 预计预测期内家庭护理将以 8.7% 的最快复合年增长率增长。
  • 由于慢性病发病率高和全国医疗保健成本上升，美国在北美注射输液帮浦市场占据主导地位。

目录

第一章调查方法与范围

第二章执行摘要

第三章北美注射输液帮浦市场变数、趋势与范围

  • 市场展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 北美注射输液帮浦市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章北美注射输液帮浦市场：依疾病类型估计与趋势分析

  • 疾病适应症细分仪表板
  • 北美注射输液帮浦市场：疾病适应症变化分析
  • 北美注射输液帮浦市场规模及趋势分析（依疾病，2018-2030）
  • 化疗
  • 糖尿病
  • 胃肠病学
  • 镇痛/疼痛管理
  • 小儿科/新生儿科
  • 血液学
  • 其他的

5. 北美注射输液帮浦市场：依最终用途的估计与趋势分析

  • 最终用途细分仪表板
  • 北美注射输液帮浦市场：最终用途差异分析
  • 2018-2030年北美注射输液帮浦市场规模及趋势分析（依最终用途）
  • 医院
  • 居家护理
  • 其他（ASC、疗养院、復健中心）

第六章北美注射输液帮浦市场：按国家/地区进行的估计和趋势分析

  • 各国市场仪表板
  • 2024 年及 2030 年各国市场
  • 北美注射输液帮浦市场（按国家/地区）关键要点
  • 美国
    • 主要国家趋势
    • 法规结构/报销结构
    • 竞争场景
  • 加拿大
    • 主要国家趋势
    • 法规结构/报销结构
    • 竞争场景
  • 墨西哥
    • 主要国家趋势
    • 法规结构/报销结构
    • 竞争场景

第七章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
  • 供应商格局
    • 2024年主要企业热图分析
  • 公司简介
    • Baxter
    • B. Braun Medical Inc.
    • Fresenius Kabi AG
    • ICU Medical, Inc.
    • Micrel Medical Devices SA
    • Boston Scientific Corporation
    • BD
    • Terumo Corporation
    • Moog Inc.
    • IRadimed Corporation
    • CODAN Companies
    • ACROMED
Product Code: GVR-4-68040-567-1

North America Syringe Infusion Pumps Market Growth and Trends:

The North America syringe infusion pumps market size is anticipated to reach USD 1.04 billion by 2030 and is expected to grow at a CAGR of 8.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is experiencing substantial growth driven by the increasing prevalence of chronic diseases, affecting approximately six in ten adults and necessitating precise, continuous medication delivery for conditions such as cancer and diabetes.

The rising number of surgical procedures and ICU admissions further amplifies demand for these pumps, crucial for delivering anesthetics and critical care medications. This is especially true considering the projected increase in U.S. hospitalizations from 36 million in 2025 to 40 million by 2035.

Technological advancements in smart infusion technologies, including Dose Error Reduction Systems (DERS) and EHR compatibility, are pivotal in enhancing medication safety and efficiency, as North America leads in their adoption. The expanding home healthcare and ambulatory care sectors, fueled by an aging population and cost-containment strategies, are increasing the demand for portable, user-friendly syringe pumps for safe medication delivery outside hospitals. Favorable regulatory environments and reimbursement policies further support the sustained growth and innovation within the market.

North America Syringe Infusion Pumps Market Report Highlights:

  • Pediatrics/neonatology held the largest revenue share of over 25.0% in 2024, owing to the critical need for precise drug delivery for newborns and infants, coupled with advancements in safety technologies and NICU/PICU investments
  • The chemotherapy segment is projected to grow at the fastest CAGR over the forecast period
  • Market growth is fueled by the critical need for precise syringe pump delivery of potent drugs, supported by safety features, and the increasing number of cancer cases.
  • Hospitals dominated the market with around 40.0% of the total revenue share in 2024 due to high demand for precise drug delivery in critical care and diverse applications.
  • Homecare is projected to grow at the fastest CAGR of 8.7% over the forecast period.
  • The U.S. dominated the North American syringe infusion pumps market, supported by the high prevalence of chronic diseases and growing national healthcare expenditure.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Disease Indication
    • 1.2.2. End Use
    • 1.2.3. Country scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Disease indication outlook
    • 2.2.2. End use outlook
    • 2.2.3. Country outlook
  • 2.3. Competitive Insights

Chapter 3. North America Syringe Infusion Pumps Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. North America Syringe Infusion Pumps Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. North America Syringe Infusion Pumps Market: Disease Indication Estimates & Trend Analysis

  • 4.1. Disease Indication Segment Dashboard
  • 4.2. North America Syringe Infusion Pumps Market: Disease Indication Movement Analysis
  • 4.3. North America Syringe Infusion Pumps Market Size & Trend Analysis, by Disease Indication, 2018 to 2030 (USD Million)
  • 4.4. Chemotherapy
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Diabetes
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Gastroenterology
    • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Analgesia/Pain Management
    • 4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Pediatrics/Neonatology
    • 4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.9. Hematology
    • 4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.10. Others
    • 4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. North America Syringe Infusion Pumps Market: End Use Estimates & Trend Analysis

  • 5.1. End Use Segment Dashboard
  • 5.2. North America Syringe Infusion Pumps Market: End Use Movement Analysis
  • 5.3. North America Syringe Infusion Pumps Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Homecare
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Others (ASC, Nursing Homes, Rehabilitation Centers)
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. North America Syringe Infusion Pumps Market: Country Estimates & Trend Analysis

  • 6.1. Country Market Dashboard
  • 6.2. Country Market Share Analysis, 2024 & 2030
  • 6.3. North America Syringe Infusion Pumps Market by country: Key Takeaways
  • 6.4. U.S.
    • 6.4.1. Key country dynamics
    • 6.4.2. Regulatory framework/ reimbursement structure
    • 6.4.3. Competitive scenario
    • 6.4.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Canada
    • 6.5.1. Key country dynamics
    • 6.5.2. Regulatory framework/ reimbursement structure
    • 6.5.3. Competitive scenario
    • 6.5.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Mexico
    • 6.6.1. Key country dynamics
    • 6.6.2. Regulatory framework/ reimbursement structure
    • 6.6.3. Competitive scenario
    • 6.6.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key company heat map analysis, 2024
  • 7.4. Company Profiles
    • 7.4.1. Baxter
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. B. Braun Medical Inc.
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Fresenius Kabi AG
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. ICU Medical, Inc.
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Micrel Medical Devices SA
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Boston Scientific Corporation
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. BD
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Terumo Corporation
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Moog Inc.
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. IRadimed Corporation
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives
    • 7.4.11. CODAN Companies
      • 7.4.11.1. Company overview
      • 7.4.11.2. Financial performance
      • 7.4.11.3. Product benchmarking
      • 7.4.11.4. Strategic initiatives
    • 7.4.12. ACROMED
      • 7.4.12.1. Company overview
      • 7.4.12.2. Financial performance
      • 7.4.12.3. Product benchmarking
      • 7.4.12.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America syringe infusion pumps market, by country, 2018 - 2030 (USD Million)
  • Table 3 North America syringe infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 4 North America syringe infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 5 U.S. syringe infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 6 U.S. syringe infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 7 Canada syringe infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 8 Canada syringe infusion pumps market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Mexico syringe infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 10 Mexico surgical ablation market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 North America syringe infusion pumps market: market outlook
  • Fig. 10 North America syringe infusion pumps competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 North America syringe infusion pumps market driver impact
  • Fig. 16 North America syringe infusion pumps market restraint impact
  • Fig. 17 North America syringe infusion pumps market strategic initiatives analysis
  • Fig. 18 North America syringe infusion pumps market: Disease indication movement analysis
  • Fig. 19 North America syringe infusion pumps market: Disease indication outlook and key takeaways
  • Fig. 20 Chemotherapy estimates and forecast, 2018 - 2030
  • Fig. 21 Diabetes estimates and forecast, 2018 - 2030
  • Fig. 22 Gastroenterology estimates and forecast, 2018 - 2030
  • Fig. 23 Analgesia/Pain management estimates and forecast, 2018 - 2030
  • Fig. 24 Pediatrics/Neonatology estimates and forecast, 2018 - 2030
  • Fig. 25 Hematology estimates and forecast, 2018 - 2030
  • Fig. 26 Others estimates and forecast, 2018 - 2030
  • Fig. 27 North America syringe infusion pumps market: End use movement analysis
  • Fig. 28 North America syringe infusion pumps market: End use outlook and key takeaways
  • Fig. 29 Hospitals estimates and forecast, 2018 - 2030
  • Fig. 30 Homecare estimates and forecast, 2018 - 2030
  • Fig. 31 Others (ASC, nursing homes, rehabilitation centers) estimates and forecast, 2018 - 2030
  • Fig. 32 North America syringe infusion pumps market: Country movement analysis
  • Fig. 33 North America syringe infusion pumps market: Country outlook and key takeaways
  • Fig. 34 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 35 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 36 Mexico market estimates and forecasts, 2018 - 2030